MENU
RYOAX
Mutual Fund ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

Rydex Biotechnology H (RYOAX) Ownership - Who owns Rydex Biotechnology H?

The investment seeks to provide capital appreciation... Show more

Category: #Health

Profile

Category
Health
Address
Rydex Series Funds9601 Blackwell Road,Suite 500Rockville
Phone
N/A
Web
www.rydex-sgi.com

Details

Group
Domestic Stock Funds
Category
Health
Total Expense Ratio
1.65
Min. Initial Investment
2500.00
Fund Existence
about 27 years
Turnover
51.00
Front Load
N/A
Net Assets
88946590.00
Manager Tenure
N/A

Fundamentals

RYOAX
Net Assets
88.9M
Fund Existence
about 27 years
Turnover
51.00
Total Expense Ratio
1.65
Front Load
N/A
Manager
N/A
Manager Tenure
N/A
Min. Initial Investment
2500
Min. Initial Investment IRA
N/A
Morningstar Category
Health
Administrative Fee
N/A
Annual Report Gross Expense Ratio
1.68
Assets in Top Ten Holdings
46.1M
Average Credit Quality
N/A
Average Effective Duration
N/A
Average Effective Maturity
N/A
Fund of Funds
No
Fund Share Class Net Assets
4.19M
Fund Type
OpenEnd
Index Fund
No
Management Fee
0.85
Modified Duration
N/A
No Load Fund
Yes
Number of Long Holdings
79.00
Number of Net Holdings
81.00
Number of Short Holdings
2.00
Prospectus Acquired Expense Ratio
N/A
Weighting Top Ten Holdings
38.36%
Gain YTD
0.755
Annual Yield % from dividends
0.00
Returns for 1 year
-15.68
Returns for 3 years
-16.81
Returns for 5 years
-13.99
Returns for 10 years
-38.42
View a ticker or compare two or three
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
Rydex Series Funds9601 Blackwell Road,Suite 500Rockville
Phone
N/A
Web
www.rydex-sgi.com